Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multim...

by Khunti, Kamlesh, Heerspink, Hiddo J. L., Lam, Carolyn S. P., University Medical Center Groningen, Groningen, Netherlands., Nicolucci, Antonio, Ramirez, Larisa, Surmont, Filip, Fenici, Peter, Kosiborod, Mikhail, University of Missouri-Kansas CityMO, United States.
Published 2022

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial

by Cherney, David Z., Dekkers, Claire C. J., Barbour, Sean J., Cattran, Daniel, Gafor, Abdul Halim Abdul, Greasley, Peter J., Laverman, Gozewijn D., Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N., Vervloet, Marc G., Wong, Muh Geot, Gansevoort, Ron T., Heerspink, Hiddo J. L., Investigators, DIAMOND
Published 2020

Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice

by Oshima, Megumi, Jardine, Meg J., Agarwal, Rajiv, Bakris, George, Cannon, Christopher P., Charytan, David M., de Zeeuw, Dick, Edwards, Robert, Greene, Tom, Levin, Adeera, Lim, Soo Kun, Mahaffey, Kenneth W., Neal, Bruce, Pollock, Carol, Rosenthal, Norman, Wheeler, David C., Zhang, Hong, Zinman, Bernard, Perkovic, Vlado, Heerspink, Hiddo J. L.
Published 2021

Evaluation of the Pharmacokinetics and Exposure–Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease

by van der Aart-van der Beek, Annemarie B., Koomen, Jeroen V., Dekkers, Claire C.J., Barbour, Sean J., Boulton, David W., Gansevoort, Ron T., Greasley, Peter J., Abdul Gafor, Abdul Halim, Laverman, Gozewijn D., Li, Qiang, Lim, Soo Kun, Stevens, Jasper, Vervloet, Marc G., Singh, Sunita, Cattran, Daniel C., Reich, Heather N., Cherney, David Z.I., Heerspink, Hiddo J.L.
Published 2021

Evaluation of the pharmacokinetics and exposure-response relationship of dapagliflozin in patients without diabetes and with chronic kidney disease

by van der van der Beek, Annemarie B., Koomen, Jeroen V., Dekkers, Claire C. J., Barbour, Sean J., Boulton, David W., Gansevoort, Ron T., Greasley, Peter J., Abdul Gafor, Abdul Halim, Laverman, Gozewijn D., Li, Qiang, Lim, Soo Kun, Stevens, Jasper, Vervloet, Marc G., Singh, Sunita, Cattran, Daniel C., Reich, Heather N., Cherney, David Z. I., Heerspink, Hiddo J. L.
Published 2021